Search icon
Learn, Analyse & Invest
only with
Orca logoArrow icon
+91
Download Orca
orca play storeorca apple store
To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Trident Texofab Ltd.

Trident Texofab

0.00

0.00 (0.00)%

NSE

BSE

EX-DatePurpose
15 04 2021 Inter alia, to consider and approve including: - 1. Appointment of an Independent Director. 2. Resignation of Mrs. Maniya H. Desai as Non-Executive (Non-Independent) Director. 3. Reconstitution of Board Committees.
28 06 2021 Quarterly Results & Audited Results
23 07 2021 Preferential Issue of shares & Increase in Authorised Capital & A.G.M. Inter alia, to consider and approve including- 1. Increase in the Authorised Share Capital and alteration of the Capital Clause of the Memorandum of Association of the Company. 2. Fund raising by way of further issue of Share.
30 07 2021 Preferential Issue of shares(Cancelled) (Cancelled)
13 08 2021 Quarterly Results
21 08 2021 Inter alia including, to consider and approve: - 1. To decide date, place, time of ensuing annual general meeting for the financial year ended on March 31, 2021 and approve notice for the same. 2. To decide closure of registrar of members and share transfer book of purpose of AGM. 3. To appoint scrutinizer for conducting businesses of AGM. 4. Any other business with the permission of the Chair.
14 09 2021 Increase in Authorised Capital Inter alia, to consider and approve Including, 1. Increase in the Authorized Share Capital and alteration of the Capital Clause of the Memorandum of Association of the Company. 2. Fund raising by way of further issue of Share. 3. Draft Postal ballot notice.
21 10 2021 Quarterly Results
19 01 2022 Quarterly Results
31 03 2022 Independent Director Meeting
21 04 2022 Audited Results Inter alia toconsider and approve including: - I. The Audited Financial results of the company for the quarter and year ended on 31st March, 2022. 2. Any other business with the permission of the Chair.
04 06 2022Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/06/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday, the 04th day of June, 2022 at 11.00 A.M. at the registered office of the Company, inter alia to consider and approve including: - 1. Re-Appointment of CS Praful N. Vekariya. as a Secretarial Auditor for the financial year 2021-22 2. Re-Appointment of Purushottam Khandelwal & Co., Chartered Accountants as an Internal Auditor for the financial year 2022-23. 3. Any other business with the permission of the Chair Thank you
09 07 2022 Inter alia to consider and approve including: 1. Resignation of Ms. Ami Ashwinbhai Desai as an Independent Director. 2. Reconstitution of Board Committees. 3. Any other business with the permission of the Chair.
12 07 2022 Quarterly Results
22 08 2022 Inter alia, to consider and approve including ; 1. To decide date, place, time of ensuing annual general meeting for the financial year ended on March 31, 2022 and approve notice for the same. 2. To decide closure of registrar of members and share transfer book of purpose of AGM. 3. To appoint scrutinizer for conducting businesses of AGM. 4. To adopt Directors Report for F.Y. 2021-22 5. Any other business with the permission of the Chair.
26 09 2022 Inter alia, to consider and approve:- 1. To Borrow or raise fund by issue of Unlisted Secured Redeemable Non-Convertible Debentures for value up to Rs. 12,00,00,000/- (Twelve Crore Only) at Face Value of Rs. 1000/- each (One Thousand Only) in terms of Section 42 and 71 of the Companies Act 2013, read with relevant rules and SEBI Regulations. 2. To Borrow or raise fund by issue of Unlisted Unsecured Compulsorily Convertible Debentures for value up to Rs. 18,00,00,000/-(Eighteen Crore Only) at Face Value of Rs. 1000/- each (One Thousand Only) in terms of Section 42 and 71 of the Companies Act 2013, read with relevant rules and SEBI Regulations. 3. Any Other business with the permission of the Chair.
01 10 2022 (Revised) The Meeting of the Board of Directors of the Company shall not be held on 26th September 2022 due to unavoidable reasons and the same has been postponed to Saturday, 01st October 2022 to consider and approve:- 1. To Borrow or raise fund by issue of Unlisted Secured Redeemable Non-Convertible Debentures for value up to Rs. 12,00,00,000/- (Twelve Crore Only) at Face Value of Rs. 1000/- each (One Thousand Only) in terms of Section 42 and 71 of the Companies Act 2013, read with relevant rules and SEBJ Regulations. 2. To Borrow or raise fund by issue of Unlisted Unsecured Compulsorily Convertible Debentures for value up to Rs. 18,00,00,000/-(Eighteen Crore Only) at Face Value of Rs. 1000/- each (One Thousand Only) in terms of Section 42 and 71 of the Companies Act 2013, read with relevant rules and SEBI Regulations
11 10 2022 Quarterly Results
16 01 2023 Quarterly Results
24 04 2023 Audited Results
10 08 2023 Quarterly Results & Inter alia to consider and approve including: 1. To approve and take on record the un-audited standalone financial results of the Company for the quarter ended June 30, 2023: 2. To Appoint a Secretarial Auditor for the financial year 2023-24. 3. To Appoint an Internal Auditor for the financial year 2023-24. 4. Any other business with the permission of the Chair.
06 11 2023 Quarterly Results
14 02 2024 Quarterly Results
13 03 2024 Independent Director Meeting
12 10 2024 Quarterly Results
23 10 2024 Inter-alia, to transact the following businesses: 1. To increase the Authorized Share Capital of the Company and consequent amendments in Memorandum of Association of the Company; 2. To consider and evaluate the proposal to raise funds, to accelerate business growth and to augment the long-term financial resources of the Company, by way of issue of Warrants/Equity Shares/Convertible Securities through permissible mode, as may be permitted under applicable laws and subject to all necessary approvals, and to appoint requisite intermediaries required for this purpose; 3. to seek members approval wherever applicable by means of passing the requisite resolution(s) for the above-said board decisions and other matters connected therewith and/or incidental thereto; and 4. Any other business with the permission of the Chair.
03 02 2025 Quarterly Results
29 05 2025 Audited Results
12 08 2025 Quarterly Results
13 08 2025 Quarterly Results (Revised)
13 11 2025 Quarterly Results & Un-Audited Financial result for Quarter and half year ended September 30, 2025
12 02 2026 Quarterly Results

News

19-SEP-2022

Trident Texofab to raise Rs 12 crore through NCDs

The company is also planning to borrow or raise fund by issue of Unlisted Unsecured Compulsorily Convertible Debentures for value up to Rs 18 crore

10:30 AM
Enrich money logo